Home
Clinical Resources Search
PQI: Proactive Symptom Management in Myelofibrosis

Proactive Symptom Management in Myelofibrosis

Download PQI pdf

Last Updated: May 28, 2024

By: Kristyn DiSogra, PharmD, BCOP | Justin Arnall, PharmD, BCOP

About this PQI

The purpose of this PQI is to highlight implementation of telehealth symptom and risk survey completion by pharmacists or other healthcare providers for myelofibrosis (MF) patients.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Proactive Symptom Management in Myelofibrosis

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Reflex Biomarker Testing in Metastatic Colorectal Cancer: Implementing BRAF and MSI Assessment

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI in Action: Darolutamide (Nubeqa)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

S10 E13: Oncology Unfiltered: AI and the Future of Cancer Care

S10 E14: Optimizing Access Through OOLD

S10 E12: Inside GU Oncology with Uromigos Co-Host

S10 E11: Your Best Meeting Ever

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S7 Ep 8: Sickle Cell Disease Insights

Momelotinib

Pacritinib

Fedratinib

Ruxolitinib

Ruxolitinib

PQI in Action: Ropeginterferon alfa-2b-njft (BESREMi®) Use in Polycythemia Vera

S10 E14: Optimizing Access Through OOLD

Ibrutinib and BR

Ibrutinib and Obinutuzumab

Vepdegestrant